Machine Learning Times
Machine Learning Times
EXCLUSIVE HIGHLIGHTS
Video – How to Use AI Ethically from Natalia Modjeska of Omdia
 Event: Machine Learning Week 2021 Keynote: How to Use AI...
Video – Alexa On The Edge – A Case Study in Customer-Obsessed Research from Susanj of Amazon
 Event: Machine Learning Week 2021 Keynote: Alexa On The Edge...
Why AI Isn’t Going to Replace Data Scientists Any Time Soon
 Should data scientists consider AI a threat to their...
“Doing AI” Is a Mistake that Detracts from Real Problem-Solving
  A note from Executive Editor Eric Siegel: Richard...
SHARE THIS:

2 weeks ago
Efficient and Targeted COVID-19 Border Testing Via Reinforcement Learning

 
Originally published in Nature, Sept 22, 2021.

Throughout the COVID-19 pandemic, countries relied on a variety of ad-hoc border control protocols to allow for non-essential travel while safeguarding public health: from quarantining all travellers to restricting entry from select nations based on population-level epidemiological metrics such as cases, deaths or testing positivity rates1,2. Here we report the design and performance of a reinforcement learning system, nicknamed ‘Eva’. In the summer of 2020, Eva was deployed across all Greek borders to limit the influx of asymptomatic travellers infected with SARS-CoV-2, and to inform border policies through real-time estimates of COVID-19 prevalence. In contrast to country-wide protocols, Eva allocated Greece’s limited testing resources based upon incoming travellers’ demographic information and testing results from previous travellers. By comparing Eva’s performance against modelled counterfactual scenarios, we show that Eva identified 1.85 times as many asymptomatic, infected travellers as random surveillance testing, with up to 2-4 times as many during peak travel, and 1.25-1.45 times as many asymptomatic, infected travellers as testing policies that only utilize epidemiological metrics. We demonstrate that this latter benefit arises, at least partially, because population-level epidemiological metrics had limited predictive value for the actual prevalence of SARS-CoV-2 among asymptomatic travellers and exhibited strong country-specific idiosyncrasies in the summer of 2020. Our results raise serious concerns on the effectiveness of country-agnostic internationally proposed border control policies3 that are based on population-level epidemiological metrics. Instead, our work represents a successful example of the potential of reinforcement learning and real-time data for safeguarding public health.

To continue reading this article, click here.

Leave a Reply